Medronic Acid

Medronic Acid

SCHEMBL1138068

NCCNCCN.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O.O=P(O)(O)CP(=O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.56
CA12 O43570 4/20 0.53
CA6 P23280 4/20 0.53
CA7 P43166 4/20 0.53
CA9 Q16790 4/20 0.53
CA14 Q9ULX7 4/20 0.53
CA5B Q9Y2D0 4/20 0.53
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 2/20 0.53
MEN1 O00255 2/20 0.53
RECQL P46063 2/20 0.53
KMT2A Q03164 2/20 0.53
MMP2 P08253 1/20 0.53
THRB P10828 1/20 0.53
MAPK1 P28482 1/20 0.53
LMNA P02545 3/20 0.50
CA2 P00918 3/20 0.50
CA4 P22748 3/20 0.50
CA5A P35218 3/20 0.50
TDP1 Q9NUW8 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Medronic Acid SCHEMBL9347974 1.00 ANPEP (0.56) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL7081257 1.00 ANPEP (0.56) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL3889431 1.00 ANPEP (0.56) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL1496457 1.00 ANPEP (0.56) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL220473 1.00 ANPEP (0.56) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL3539311 0.97 CA12 (0.55) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL2944253 0.97 ANPEP (0.54) ANPEPCA12CA6CA7CA9
Medronic Acid SCHEMBL2126902 0.97 ANPEP (0.54) ANPEPCA12CA6CA7CA9
Trientine SCHEMBL9564313 0.97 CA12 (0.55) ANPEPCA12CA6CA7CA9
Trientine SCHEMBL242925 0.97 CA12 (0.55) ANPEPCA12CA6CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576213-B1 Reacting metal chlorates with hydrogen peroxide stabilized with hydroxyethylidenediphosphonic acid; bleaches; water treatment EKA CHEMICALS, INC. (SE) 2003-06-10 US claimed
US-11779013-B2 Stabilized peroxyacid solutions EVONIK CORPORATION (US) 2023-10-10 US disclosed
US-20210363008-A1 PROCESS FOR PREPARING A STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTION EVONIK CORPORATION (US) 2021-11-25 US disclosed
US-20210307332-A1 POLYMER-STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTIONS AND ASSOCIATED METHODS EVONIK CORPORATION (US) 2021-10-07 US disclosed
US-20210219543-A1 STABILIZED PEROXYACID SOLUTIONS EVONIK CORPORATION (US) 2021-07-22 US disclosed
US-20210206635-A1 STABILIZED HYDROGEN PEROXIDE-CHLORATE MIXTURES EVONIK CORPORATION (US) 2021-07-08 US disclosed
EP-3829306-A1 STABILIZED PEROXYACID SOLUTIONS Evonik Corporation (US) 2021-06-09 EP disclosed
EP-3830023-A1 STABILIZED HYDROGEN PEROXIDE-CHLORATE MIXTURES Evonik Corporation (US) 2021-06-09 EP disclosed
EP-3830027-A1 POLYMER-STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTIONS AND ASSOCIATED METHODS Evonik Corporation (US) 2021-06-09 EP disclosed
WO-2020028652-A1 STABILIZED HYDROGEN PEROXIDE-CHLORATE MIXTURES EVONIK CORPORATION (US) 2020-02-06 WO disclosed
WO-2020028655-A1 POLYMER-STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTIONS AND ASSOCIATED METHODS EVONIK CORPORATION (US) 2020-02-06 WO disclosed
WO-2020028657-A1 STABILIZED PEROXYACID SOLUTIONS EVONIK CORPORATION (US) 2020-02-06 WO disclosed
US-8034227-B2 Chemical process AKZO NOBEL N.V. (NL) 2011-10-11 US disclosed
EP-2038215-B1 PROCESS FOR THE PRODUCTION OF HYDROGEN PEROXIDE AKZO NOBEL NV (NL) 2011-02-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210307332-A1 POLYMER-STABILIZED AQUEOUS HYDROGEN PEROXIDE SOLUTIONS AND ASSOCIATED METHODS GPX4, PSPH, PHOSPHO1 ANPEP 2289/4885CA12 906/4885CA6 1089/4885
US-11779013-B2 Stabilized peroxyacid solutions PGD, ACMSD, ALAD ANPEP 3424/4885CA12 1833/4885CA6 1246/4885
US-20210219543-A1 STABILIZED PEROXYACID SOLUTIONS PGD, ACMSD, ALAD ANPEP 3424/4885CA12 1833/4885CA6 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.